The pattern of esophageal manometry in progressive systemic sclerosis

Saudi Medical Journal

Volumn 24, Issue 1, 2003, Pages 68-71

  Al Amri, Saleh M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT;

ADULT; AGE; AMBULATORY MONITORING; AMPLITUDE MODULATION; ANAMNESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG WITHDRAWAL; DYSPHAGIA; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; FEMALE; FREQUENCY ANALYSIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GENDER; HEARTBURN; HUMAN; LOWER ESOPHAGUS SPHINCTER PRESSURE; MALE; MUSCLE CONTRACTION; PH MEASUREMENT; SAUDI ARABIA; SCORING SYSTEM; SYMPTOMATOLOGY; SYSTEMIC SCLEROSIS; TIME; UNIVERSITY HOSPITAL; UPPER GASTROINTESTINAL TRACT;

ADULT; DEGLUTITION DISORDERS; ESOPHAGUS; FEMALE; HEARTBURN; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MANOMETRY; MONITORING, AMBULATORY; PERISTALSIS; PRESSURE; SCLERODERMA, DIFFUSE;

EID: 0037227825     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Yarze JC, Varga J, Stamfl D, Castell DO, Jimenez SA. Esophageal Function in Systemic Sclerosis: A prospective evaluation of motility and acid reflux in 36 patients. Am J Gastroenterol 1993; 88: 870-876.
2. Drane WE, Karvelis K, Johnson DA, Curran JJ, Silverman ED. Progressive Systemic Sclerosis: Radionuclide Esophageal Scintigraphy and Manometry. Radiology 1986; 160: 73-76.
3. Poirier TJ, Ranklin GB. Gastrointestinal manifestation of progressive systemic scleroderma based on a review of 364 cases. Am J Gastroenterol 1972; 58: 30-44.
4. Lock G, Pfeifer M, Straub RH, Zeuner M, Lang B, Scholmering J et al. Association of Esophageal Dysfunction and Pulmonary Function Impairment in Systemic Sclerosis. Am J Gastroenterol 1998; 93: 341-345.
5. Orringer MB, Dabich L, Zarafonetis CJD, Sloan H. Gastroesophageal reflux in esophageal scleroderma: Diagnosis and implications. Ann Thorac Surg 1976; 22: 120-130.
6. Murphy JR, McNally P, Peller P, Shay SS. Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis. Dig Dis Sci 1992; 37: 833-841.
7. Petrokubi RJ, Jeffries GH. Cimetidine versus antacid in scleroderma with reflux esophagitis: A randomized double-blind controlled study. Gastroenterol 1979; 77: 691-695.
8. Lock G, Holstege A, Lang B, Scholmerich J. Gastrointestinal manifestations of progressive systemic sclerosis. Am J Gastroenterol 1997; 92: 763-771
9. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590.
10. Cohen S, Laufer I, Snape WJ, Shiau YF, Levine G, Jimenez S et al. The gastrointestinal manifestation of scleroderma: pathologenesis and management. Gastroenterol 1980; 79: 155-166.
11. Summerling AM. Oesophageal changes in systemic sclerosis. Gut 1966; 7: 402-408.
12. Turner R, Lipshutz W, Miller W, Rittenberg G, Schumacher HR, Cohen S. Esophageal dysfunction in colllagen disease. Am J Med Sci 1973; 265: 191-199.
13. Kahrilas PJ, Dodds WJ, Hogan WJ, Kern M, Amdorfer RC, Reece A. Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterol 1986; 91: 897-904.
14. Gill RC, Bowes KL, Murphy PD, Kingma YJ. Esophageal motor abnormalities in gastroesophageal reflux and the effects of fundoplication. Gastroenterol 1986; 91: 364-369.
15. Zamost GJ, Hirshberg J, Ippoliti AF, Furst DE, Clements PJ, Weinstein WM et al. Esophagitis in sclelroderma. Prevalence and risk factors. Gastroenterol 1987; 92: 421-428.
16. Zaninotto G, Peserico A, Costantini M, Salvador L, Rondinone R, Roveran A et al. Oesophageal motility and lower eosophageal sphincter competence in progressive systemic sclerosis and localized scleroderma. Scand J Gastroenterol 1989; 24: 95-102.